Share Twitter LinkedIn Facebook Email Frederick Locke, MD, Program Co-Leader, Immunology Moffitt Cancer Center, discusses Improvements To Turn Around Time With CAR-T Therapies. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Cell Therapy for Solid Tumors: Immunotherapy Biomarkers Anusha Kalbasi, MD MOASC [2023] Immunotherapy 2 Mins Read